CYP-LAD
From Wikipedia, the free encyclopedia
 |
This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (May 2008) |
 |
|
|---|---|
| Systematic (IUPAC) name | |
| (6aR,9R)-N,N-diethyl-7-cyclopropyl-4,6,6a,7,8,9- |
|
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | Controlled in the United States via the Federal Analog Act |
| Routes | Oral |
| Pharmacokinetic data | |
| Metabolism | hepatic |
| Excretion | renal |
| Identifiers | |
| ATC code | ? |
| ChemSpider | 21106273  |
| Synonyms | CYP-LAD, 6-cyclopropyl-6-nor-Lysergic acid diethylamide |
| Chemical data | |
| Formula | C22H27N3O |
| Mol. mass | 349.48 g/mol |
| SMILES | eMolecules & PubChem |
|
|
 (what is this?) (verify) |
|
CYP-LAD, also known as 6-cyclopropyl-6-nor-lysergic acid diethylamide, is an analogue of LSD.
CYP-LAD has been sold by some research chemical suppliers but might be considered illegal in some countries due to its structural similarity to LSD.
 |
This psychedelics, dissociatives and deliriants-related article is a stub. You can help Wikipedia by expanding it. |
